Featured

Adult stem cell transplantation for the treatment of SCD



Published
Josh Wright, BMedSci (Hons), MBChB, FRCPath, MD, BSH president, discusses a presentation at BSH 2022 which focused on the use of adult stem cell transplantation for the treatment of sickle cell disease (SCD). Dr Wright further highlights the excitement around this novel treatment approach, and the benefits of being able to offer novel therapeutic options for patients with SCD. This interview took place at the 62nd Annual Scientific Meeting of the British Society for Haematology (BSH) 2022, in Manchester, UK.
Category
Health
Be the first to comment